Trial Profile
Study to identify genes predictive of treatment response in patients with myelodysplastic syndromes and acute myeloid leukemia, treated with 5-azacitidine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Biomarker; Therapeutic Use
- 11 Aug 2015 New trial record